Skip to main content

Two site evaluation of the performance of a new generation point-of-care glucose meter for use in a neonatal intensive care unit.

Tendl KA, Christoph J, Bohn A, Herkner KR, Pollak A, Prusa AR

Publication: Clin Chem Lab Med (2013) • Vol 51 • Page 1747-54PMID: 23612555View on PubMed

Purpose

The purpose of this paper was to determine the effects of medications and levels of other clinical chemistry analytes on the levels of glucose in blood from neonatal intensive care unit (NICU) patients using two different clinical chemistry analyzers.

Conclusion

Glucose levels measured by the StatStrip glucose meter or the ABL glucose meter were very strongly correlated throughout the range of levels, but there was a small negative bias for levels measured by the StatStrip device that increased with increasing glucose levels. Hematocrit, pH, partial pressure oxygen, sodium, or medication did not affect the accuracy of glucose measurements with StatStrip (ABL used as reference).

Studies (1)

Purpose

The purpose of this study was to determine the effects of medications and levels of other clinical chemistry analytes on the levels of glucose in blood from NICU patients using two different clinical chemistry analyzers. Blood was obtained by an unspecified method from 1-62 day old (23.14-41.29 weeks gestation) NICU patients. Blood was first assayed using an ABL analyzer and then with the StatStrip glucose meter.

Summary of Findings

Glucose levels measured by the StatStrip glucose meter or the ABL glucose meter were very strongly correlated (r2=0.975) throughout the range of levels with a mean bias of -4.52% for levels measured by the StatStrip device. The mean StatStrip bias was -4.03% when glucose levels were <75 mg/dL and -3.07% for specimens with <45 mg/dL glucose. Hematocrit, pH, partial pressure oxygen, sodium, or medication did not affect the accuracy of glucose measurements with StatStrip (ABL used as reference).
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Cardiovascular Disease
    Other diagnoses
  • Platforms

    CarbohydrateClinical chemistry/auto analyzer
    Electrolyte/MetalClinical chemistry/auto analyzer
    GasClinical chemistry/auto analyzer
    Small moleculeClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    122-145 mmol/L sodium
    13-389 mg/dL glucose
    25-59 mm Hg PO2
    25-77% hematocrit
    pH of 7.15-7.39
    PreaquisitionDiagnosis/ patient condition
    Child of diabetic mother
    Congenital heart disease
    Congenital infection
    Hyperbilirubinaemia
    Meconium aspiration
    Necrotizing enterocolitis
    Prenatal asphyxia
    Respiratory disease
    PreaquisitionOther drugs
    Caffeine
    Paracetamol
    Vitamin C
    Clinical chemistry/auto analyzer SpecificTechnology platform
    ABL glucose meter
    StatStrip glucose meter